Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Acquired Agranulocytosis
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Condition 101
What are the alternative names for Acquired Agranulocytosis?
Agranulocytosis, acquired
Top Global Doctors
Click to see doctor options
Elite
Gary H. Lyman
Oncology
Internal Medicine
Seattle, WA
Click to see doctor options
Elite
Matti S. Aapro
Genolier, VD, CH
Click to see doctor options
Elite
Andriy Krendyukov
Holzkirchen, BY, DE
Click to see doctor options
HL
Elite
Hartmut Link
Kaiserslautern, RP, DE
Click to see doctor options
SA
Elite
Shin Y. Ahn
Seoul, 11, KR
Click to see doctor options
JC
Elite
Jeffrey A. Crawford
Hematology
Oncology
Internal Medicine
Chapel Hill, NC
Latest Research
Latest Advance
Study
Condition:
Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma
Journal:
Lancet (London, England)
Treatment Used:
dose-dense weekly paclitaxel versus 3- weekly carboplatin
Number of Patients:
1566
Published —
December 04, 2019
The purpose of the study was to compare efficacy and safety of dose-dense weekly paclitaxel versus 3- weekly carboplatin for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.
Latest Advance
Study
Condition:
Metastatic Breast Cancer
Journal:
Future oncology (London, England)
Treatment Used:
Eribulin Mesylate
Number of Patients:
0
Published —
October 30, 2019
The aim of this study was to examine the effectiveness of eribulin mesylate for patients with metastatic breast cancer.
Latest Advance
Study
Condition:
Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)
Journal:
American journal of hematology
Treatment Used:
Duvelisib (IPI-145) with Rituximab or Bendamustine/Rituximab
Number of Patients:
46
Published —
September 07, 2019
This study determined whether combining duvelisib with either rituximab alone or rituximab and bendamustine may improve response rates and remission durability in patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Latest Advance
Study
Condition:
Acute Myeloid Leukemia (AML)
Journal:
Annals of hematology
Treatment Used:
Venetoclax
Number of Patients:
23
Published —
June 13, 2019
This study evaluated the effectiveness of venetoclax for patients with acute myeloid leukemia (AML).
Clinical Trials
Clinical Trial
Diagnostic Test
Status:
Recruiting
Study Type:
Diagnostic Test
Participants:
100
Start Date:
October 4, 2017
Predictive Value of ProCalcitonin for the Detection of Bacteraemia in Patients Presenting to the Emergency Department for Low Risk Chemo-induced Febrile Neutropenia According to the MASCC Score: a Prospective, Monocentric Observational Study (CALIF)
